tirzepatide while breastfeeding Alexandra Sowa, MD | A big win for women's health: low-dose (2.5mg + 5mg) has now been deemed safe in breastfeeding. 🍼✨ is vital for tirzepatide while breastfeeding can you

Trial Registration The trials were registered at ClinicalTrials.gov (identifiers: NCT02054897, NCT01930188, NCT01885208, NCT01720446 and NCT02207374)

Ozempic, manufactured by Novo Nordisk, is a glucagon-like peptide-1 (GLP-1) receptor agonist

Italian guidelines for the management of adult individuals with overweight and obesity and metabolic comorbidities that are resistant to behavioral treatment

Subcutaneous injection Subcutaneous injection remains the reference standard for peptide administration

*For full details on both common and serious side effects see the medication guide or talk to your healthcare provider or pharmacist

Ozempic has been hailed as a gamechanger in the pharmaceutical industry